These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12746770)

  • 1. Imported Lassa fever in Germany: surveillance and management of contact persons.
    Haas WH; Breuer T; Pfaff G; Schmitz H; Köhler P; Asper M; Emmerich P; Drosten C; Gölnitz U; Fleischer K; Günther S
    Clin Infect Dis; 2003 May; 36(10):1254-8. PubMed ID: 12746770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lassa fever. Effective therapy with ribavirin.
    McCormick JB; King IJ; Webb PA; Scribner CL; Craven RB; Johnson KM; Elliott LH; Belmont-Williams R
    N Engl J Med; 1986 Jan; 314(1):20-6. PubMed ID: 3940312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa fever (arenaviruses) as a public health problem.
    Fabiyi A
    Bull Pan Am Health Organ; 1976; 10(4):335-7. PubMed ID: 1026322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study.
    Kernéis S; Koivogui L; Magassouba N; Koulemou K; Lewis R; Aplogan A; Grais RF; Guerin PJ; Fichet-Calvet E
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e548. PubMed ID: 19924222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific antibody response to Lassa virus in the local population of west Africa.
    Emmerich P; Günther S; Schmitz H
    J Clin Virol; 2008 May; 42(1):40-4. PubMed ID: 18164653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New opportunities for field research on the pathogenesis and treatment of Lassa fever.
    Khan SH; Goba A; Chu M; Roth C; Healing T; Marx A; Fair J; Guttieri MC; Ferro P; Imes T; Monagin C; Garry RF; Bausch DG;
    Antiviral Res; 2008 Apr; 78(1):103-15. PubMed ID: 18241935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A man with fatal Lassa fever following a stay in Sierra Leone].
    Veldkamp PJ; Schippers EF
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2201-4. PubMed ID: 12467165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa.
    Emmerich P; Thome-Bolduan C; Drosten C; Gunther S; Ban E; Sawinsky I; Schmitz H
    J Clin Virol; 2006 Dec; 37(4):277-81. PubMed ID: 16996789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serological survey of Lassa fever in Liberia.
    Bloch A
    Bull World Health Organ; 1978; 56(5):811-3. PubMed ID: 310723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods.
    Grahn A; Bråve A; Tolfvenstam T; Studahl M
    Emerg Infect Dis; 2018 Jun; 24(6):978-987. PubMed ID: 29775178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The first imported case of Lassa fever in Japan].
    Hirabayashi Y; Oka S; Goto H; Shimada K; Kurata T; Fisher-Hoch SP; McCormick JB
    Nihon Rinsho; 1989 Jan; 47(1):71-5. PubMed ID: 2724572
    [No Abstract]   [Full Text] [Related]  

  • 13. A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection.
    Bond N; Schieffelin JS; Moses LM; Bennett AJ; Bausch DG
    Am J Trop Med Hyg; 2013 Feb; 88(2):241-4. PubMed ID: 23390223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast].
    Akoua-Koffi C; Ter Meulen J; Legros D; Akran V; Aïdara M; Nahounou N; Dogbo P; Ehouman A
    Med Trop (Mars); 2006 Oct; 66(5):465-8. PubMed ID: 17201291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and study of properties of immunoglobulins against Lassa fever].
    Krasnianskiĭ VP; Gradoboev VN; Borisevich IV; Potryvaeva NV; Lebedinskaia EV; Chernikova NK; Timan'kova GD
    Vopr Virusol; 1997; 42(4):168-71. PubMed ID: 9304297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa fever: immuno-epidemiological approach to the study of an endemic viral haemorrhagic fever.
    ter Meulen J
    Med Trop (Mars); 2000; 60(2 Suppl):20-3. PubMed ID: 11100455
    [No Abstract]   [Full Text] [Related]  

  • 17. Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals.
    Demby AH; Inapogui A; Kargbo K; Koninga J; Kourouma K; Kanu J; Coulibaly M; Wagoner KD; Ksiazek TG; Peters CJ; Rollin PE; Bausch DG
    Vector Borne Zoonotic Dis; 2001; 1(4):283-97. PubMed ID: 12653128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.
    Wulff H; Johnson KM
    Bull World Health Organ; 1979; 57(4):631-5. PubMed ID: 118812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria.
    Fabiyi A; Tomori O; Pinneo P
    Niger Med J; 1979 Jan; 9(1):23-5. PubMed ID: 463337
    [No Abstract]   [Full Text] [Related]  

  • 20. Lassa fever, Nigeria, 2003 and 2004.
    Omilabu SA; Badaru SO; Okokhere P; Asogun D; Drosten C; Emmerich P; Becker-Ziaja B; Schmitz H; Günther S
    Emerg Infect Dis; 2005 Oct; 11(10):1642-4. PubMed ID: 16355508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.